Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

NCT04863703 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT04863703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Active, not recruiting
Start date
May 7, 2021
Completion date
December 31, 2026
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis d, liver cirrhosis, portal hypertension